Pesquisas alternativas:
doses devel » dose level (Expandir a Pesquisa), doses derived (Expandir a Pesquisa), doses devoid (Expandir a Pesquisa)
does devel » does level (Expandir a Pesquisa), does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
doses devel » dose level (Expandir a Pesquisa), doses derived (Expandir a Pesquisa), doses devoid (Expandir a Pesquisa)
does devel » does level (Expandir a Pesquisa), does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
101
Por Guasti, Luigina, Gaudio, Giovanni, Lupi, Alessandro, D’Avino, Marinella, Sala, Carla, Mugellini, Amedeo, Vulpis, Vito, Felis, Salvatore, Sarzani, Riccardo, Vanasia, Massimo, Maffioli, Pamela, Derosa, Giuseppe
Publicado no Drug Des Devel Ther (2017)
“... treated with the highest tolerated dose of angiotensin-converting enzyme (ACE) inhibitors or angiotensin...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
102
Por Kim, Seokuee, Lee, SeungHwan, Cho, Joo-Youn, Yoon, Seo Hyun, Jang, In-Jin, Yu, Kyung-Sang
Publicado no Drug Des Devel Ther (2017)
“... the oral administration of single and multiple doses to healthy volunteers. The study comprised 2...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
103
Por Ihm, Sang-Hyun, Jeon, Hui-Kyung, Cha, Tae-Joon, Hong, Taek-Jong, Kim, Sang-Hyun, Lee, Nae-Hee, Yoon, Jung Han, Yoon, Namsik, Hwang, Kyung-Kuk, Jo, Sang-Ho, Youn, Ho-Joong
Publicado no Drug Des Devel Ther (2016)
“...PURPOSE: To evaluate the blood pressure (BP) lowering efficacy and safety of CKD-828, a fixed-dose...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
104
Por Gan, Taiping, Wang, Yuji, Zhao, Ming, Wu, Jianhui, Yang, Jian, Peng, Shiqi
Publicado no Drug Des Devel Ther (2016)
“... dose dependently inhibited the metastasis of LLC (Lewis Lung Carcinoma) toward lung. In vivo, 2 µmol/kg...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
105
Por Park, Jin-Sun, Shin, Joon-Han, Hong, Taek-Jong, Seo, Hong-Seog, Shim, Wan-Joo, Baek, Sang-Hong, Jeong, Jin-Ok, Ahn, Youngkeun, Kang, Woong-Chol, Kim, Young-Hak, Kim, Sang-Hyun, Hyon, Min-Su, Choi, Dong-Hoon, Nam, Chang-Wook, Park, Tae-Ho, Lee, Sang-Chol, Kim, Hyo-Soo
Publicado no Drug Des Devel Ther (2016)
“... compliance. This study aimed to evaluate the efficacy and safety of fixed-dose combination (FDC) therapy...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
106
107
“... once daily infusion and does not require dose adjustments for renal or moderate hepatic dysfunction...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
108
Por Mumoli, Laura, Palleria, Caterina, Gasparini, Sara, Citraro, Rita, Labate, Angelo, Ferlazzo, Edoardo, Gambardella, Antonio, De Sarro, Giovambattista, Russo, Emilio
Publicado no Drug Des Devel Ther (2015)
“... requires dose adjustment. BRV does not seem to influence other antiepileptic drug plasma levels. Six...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
109
Por Coppola, Giangennaro, Iapadre, Giulia, Operto, Francesca Felicia, Verrotti, Alberto
Publicado no Drug Des Devel Ther (2017)
“...Currently, a number of novel anticonvulsant drugs, the so-called third generation, are in various...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
110
Por Urbina, Olatz, Ferrández, Olivia, Espona, Mercè, Salas, Esther, Ferrández, Irene, Grau, Santiago
Publicado em 2013
“... with tedizolid when used at the therapeutic dose of 200 mg in Phase I, II, or III clinical trials of up to 3...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
111
Por Blandizzi, Corrado, Viscomi, Giuseppe Claudio, Scarpignato, Carmelo
Publicado no Drug Des Devel Ther (2014)
“... was specifically prepared for the study and formulated as the marketed product. Two doses (200 mg and 400 mg...”Publicado no Drug Des Devel Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
112
Por Hoch, Matthias, Darpo, Borje, Remenova, Tatiana, Stoltz, Randall, Zhou, Meijian, Kaufmann, Priska, Bruderer, Shirin, Dingemanse, Jasper
Publicado no Drug Des Devel Ther (2014)
“... were randomized to receive escalating doses of selexipag (n=91) or placebo/moxifloxacin (n=68...”Publicado no Drug Des Devel Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
113
“... that undergoes primarily renal elimination and does not affect cytochrome P450 enzymes. Assays to quantify...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
114
Por Mok, Chi Chiu
Publicado em 2013
“... for the treatment of rheumatoid arthritis (RA) that does not respond adequately to disease-modifying antirheumatic...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
115
Por Cossu, Maria Vittoria, Cattaneo, Dario, Fucile, Serena, Pellegrino, Paolo, Baldelli, Sara, Cozzi, Valeria, Capetti, Amedeo, Clementi, Emilio
Publicado em 2014
“... and to optimize the dosing of the combination of the drugs isosorbide dinitrate, a nitric oxide donor...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
116
Por Doupis, John
Publicado em 2014
“... preclinical profile, linagliptin is unique among available dipeptidyl peptidase-4 compounds because it does...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
117
Por Darkovska-Serafimovska, Marija, Janevik-Ivanovska, Emilija, Djorgoski, Icko, Arsova-Sarafinovska, Zorica, Zdravkovska, Milka, Balkanov, Trajan, Ugresic, Nenad
Publicado no Drug Des Devel Ther (2016)
“... aggregation of human platelets in a dose- and concentration-dependent manner (10 nM to 2 μM), but only...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
118
Por Guo, Yan, Sun, Juan, Ye, Juan, Ma, Wenyu, Yan, Hualing, Wang, Gang
Publicado no Drug Des Devel Ther (2016)
“...), S. tridactyla Sch. Bip.-derived polysaccharides and flavones low-dose group, and S. tridactyla Sch. Bip.-derived...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
119
Por Amato, Bruno, Compagna, Rita, Rocca, Aldo, Bianco, Tommaso, Milone, Marco, Sivero, Luigi, Vigliotti, Gabriele, Amato, Maurizio, Danzi, Michele, Aprea, Giovanni, Gallelli, Luca, de Franciscis, Stefano, Serra, Raffaele
Publicado no Drug Des Devel Ther (2016)
“... asymptomatic pulmonary embolism (APE). In most cases, these patients are treated with anticoagulant drugs...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
120
Por Aljimaee, Yazeed HM, El-Helw, Abdel-Rahim M, Ahmed, Osama AA, El-Say, Khalid M
Publicado no Drug Des Devel Ther (2015)
“...-pass metabolism, the absolute bioavailability of CVD does not exceed 30%. To overcome these drawbacks...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo